2015
Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer
Park H, Wang E, Corso C, Rutter C, Wilson L, Kim A, Gross C, Yu J, Decker R. Higher Facility Case Volume of Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival in Clinical Stage I Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s186-s187. DOI: 10.1016/j.ijrobp.2015.07.447.Peer-Reviewed Original ResearchPostoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung Cancer
Wang E, Corso C, Rutter C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e388-e389. DOI: 10.1016/j.ijrobp.2015.07.1538.Peer-Reviewed Original ResearchAssociation Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer
Wang E, Corso C, Park H, Chen A, Kim A, Wilson L, Decker R, Yu J. Association Between Radiation Dose and Outcomes With Postoperative Radiation Therapy for N0-N1 Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e387-e388. DOI: 10.1016/j.ijrobp.2015.07.1536.Peer-Reviewed Original ResearchPostoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer
Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer. Journal Of Clinical Oncology 2015, 33: 2727-2734. PMID: 26101240, DOI: 10.1200/jco.2015.61.1517.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungDatabases, FactualFemaleHumansKaplan-Meier EstimateLogistic ModelsLung NeoplasmsMaleMiddle AgedNeoplasm StagingNeoplasm, ResidualPneumonectomyRadiotherapy DosageRadiotherapy, AdjuvantRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRegistriesRetrospective StudiesTreatment OutcomeUnited StatesConceptsUse of PORTPostoperative radiotherapyOverall survivalNodal stageStage IIMultivariable analysisPatient populationLung cancerNon-small cell lung cancerOverall American Joint CommitteeNational Cancer Data BaseImproved overall survivalLower nodal stagePostoperative radiation therapyPositive surgical marginsAmerican Joint CommitteeCancer stage IICell lung cancerProportional hazards regressionMultivariable logistic regressionClinicopathologic covariatesChemotherapy receiptPerioperative mortalityOnly patientsSuch patients
2011
Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung Cancer
Park H, Decker R, Wilson L, Yu J. Prophylactic Cranial Irradiation for High-Risk Patients with Locally Advanced Non-small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s627. DOI: 10.1016/j.ijrobp.2011.06.1866.Peer-Reviewed Original ResearchVorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study
Decker R, Gettinger S, Glazer P, Wilson L. Vorinostat, a Histone Deacetylase Inhibitor, in Combination with Thoracic Radiotherapy in Advanced Non-small Cell Lung Cancer: A Dose Escalation Study. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s574-s575. DOI: 10.1016/j.ijrobp.2011.06.1074.Peer-Reviewed Original Research
2008
Evaluation of the Role of Surgery in the Management of Limited/Early Stage (I-II) Small Cell Lung Cancer from the SEER database (1988-2004)
Wilson L, Decker R, Yu J. Evaluation of the Role of Surgery in the Management of Limited/Early Stage (I-II) Small Cell Lung Cancer from the SEER database (1988-2004). International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s448. DOI: 10.1016/j.ijrobp.2008.06.1830.Peer-Reviewed Original ResearchAdvances in Radiotherapy for Lung Cancer
Decker R, Wilson L. Advances in Radiotherapy for Lung Cancer. Seminars In Respiratory And Critical Care Medicine 2008, 29: 285-290. PMID: 18506666, DOI: 10.1055/s-2008-1076748.Peer-Reviewed Original ResearchConceptsLung cancerAggressive local therapyEarly lung tumorsProphylactic cranial irradiationPositron emission tomographic imagingDefinitive treatment optionCell lung cancerRole of radiosurgeryOngoing clinical investigationsEmission tomographic imagingNormal tissue toxicityCranial irradiationPalliative therapyPostoperative radiationLocal therapyLung irradiationAdvanced tumorsTreatment optionsCancer helpLung tumorsRadiation therapyClinical investigationRadiation treatment planningTissue toxicityTherapy
2005
The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results Database
Lally B, Wilson L. The Impact of Radiotherapy for Post-operative Patients with Stage II or Stage III Non-Small Cell Lung Cancer Utilizing the Surveillance, Epidemiology, and End Results Database. International Journal Of Radiation Oncology • Biology • Physics 2005, 63: s102-s103. DOI: 10.1016/j.ijrobp.2005.07.176.Peer-Reviewed Original Research